Page last updated: 2024-11-02

pentamidine and Leukemia, Monocytic, Acute

pentamidine has been researched along with Leukemia, Monocytic, Acute in 2 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Leukemia, Monocytic, Acute: An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Sullivan, BP1
Spaulding, R1
Gebre-Hiwot, A1
Tadesse, G1
Croft, SL1
Frommel, D1

Trials

1 trial available for pentamidine and Leukemia, Monocytic, Acute

ArticleYear
The use of aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in children with leukemia.
    Pediatric pulmonology, 1994, Volume: 18, Issue:4

    Topics: Adolescent; Aerosols; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Immunosuppr

1994

Other Studies

1 other study available for pentamidine and Leukemia, Monocytic, Acute

ArticleYear
An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
    Acta tropica, 1992, Volume: 51, Issue:3-4

    Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Evaluation, Preclinical; Humans; Leis

1992